DK1206476T3 - 9a-azalider med antibakteriel virkning - Google Patents

9a-azalider med antibakteriel virkning

Info

Publication number
DK1206476T3
DK1206476T3 DK00955256T DK00955256T DK1206476T3 DK 1206476 T3 DK1206476 T3 DK 1206476T3 DK 00955256 T DK00955256 T DK 00955256T DK 00955256 T DK00955256 T DK 00955256T DK 1206476 T3 DK1206476 T3 DK 1206476T3
Authority
DK
Denmark
Prior art keywords
azalides
antibacterial action
antibacterial
action
Prior art date
Application number
DK00955256T
Other languages
English (en)
Inventor
Yat Sun Or
Robert F Keyes
Zhenkun Ma
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1206476T3 publication Critical patent/DK1206476T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK00955256T 1999-08-24 2000-07-26 9a-azalider med antibakteriel virkning DK1206476T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38216699A 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
DK1206476T3 true DK1206476T3 (da) 2006-05-15

Family

ID=23507795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00955256T DK1206476T3 (da) 1999-08-24 2000-07-26 9a-azalider med antibakteriel virkning

Country Status (15)

Country Link
EP (1) EP1206476B1 (da)
JP (1) JP2003507487A (da)
AR (1) AR025379A1 (da)
AT (1) ATE315042T1 (da)
AU (1) AU6748500A (da)
BR (1) BR0009101A (da)
CA (1) CA2380455C (da)
CY (1) CY1104996T1 (da)
DE (1) DE60025370T2 (da)
DK (1) DK1206476T3 (da)
ES (1) ES2256030T3 (da)
HK (1) HK1047940B (da)
MX (1) MXPA02001897A (da)
PT (1) PT1206476E (da)
WO (1) WO2001014397A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
SI8611592A8 (en) * 1986-09-12 1995-04-30 Pliva Pharm & Chem Works Process for preparing complexes of N-methyl-11-aza-10-deoxo-10-dihydroeritromicine A and 11-aza-10-deoxo-10-dihydroeritromicine A with metals
US5686587A (en) * 1993-05-19 1997-11-11 Pfizer Inc. Intermediate for azithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
WO1999000124A1 (en) * 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
AU7986098A (en) * 1997-06-27 1999-01-19 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1101769A3 (en) * 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives

Also Published As

Publication number Publication date
EP1206476B1 (en) 2006-01-04
HK1047940B (en) 2006-11-03
DE60025370D1 (de) 2006-03-30
CA2380455A1 (en) 2001-03-01
JP2003507487A (ja) 2003-02-25
PT1206476E (pt) 2006-05-31
EP1206476A1 (en) 2002-05-22
AR025379A1 (es) 2002-11-20
MXPA02001897A (es) 2002-10-31
WO2001014397A1 (en) 2001-03-01
AU6748500A (en) 2001-03-19
CY1104996T1 (el) 2010-03-03
DE60025370T2 (de) 2006-09-21
HK1047940A1 (en) 2003-03-14
CA2380455C (en) 2009-06-02
ES2256030T3 (es) 2006-07-16
BR0009101A (pt) 2002-02-05
ATE315042T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1224180E (pt) Azois substituidos
DE122007000064I2 (de) Erythropoietinkonjugate
DE10084676T1 (de) Einmallanzettvorrichtung
NO20015722D0 (no) Antibakterielle forbindelser
PT1218009E (pt) Grandulos de quetiapina
PT1218096E (pt) Microcapsulas de libertacao variavel
NO20020621D0 (no) Antibakterielle midler
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
PT1163256E (pt) Hemi-hidrato de 16-alfa-bromoepiandrosterona
ATE264843T1 (de) Antibakterielle mutiline
ATE248579T1 (de) Synergistische antibakterielle kombination
DK1206476T3 (da) 9a-azalider med antibakteriel virkning
PT1235566E (pt) Formulacao injectavel de valnemulina
DE50007972D1 (de) Elastische Walze
NO20022927L (no) Substituerte pyrrazoler
ID25567A (id) Ulir-jepit dengan bahu-puntir
DE10082008D2 (de) Ausbeulgerät
PT1190776E (pt) Pulverizador de liquidos
DK1200423T3 (da) Substituerede pehnyluraciler
NO992540D0 (no) L°ftetralle